[ X
]
|
Annual
Report Pursuant to Section 15(d) of the Securities Exchange Act of 1934
for the Fiscal Year Ended December 31,
2008
|
[ ]
|
Transition
Report Pursuant to Section 15(d) of the Securities Exchange Act of
1934
|
A.
|
Full
title of the plan and address of the plan, if different from that of the
issuer named below:
|
B.
|
Name
of issuer of the securities held pursuant to the plan and the address of
the principal executive office:
|
|
Thermo
Fisher Scientific Inc.
|
|
81
Wyman Street
|
|
Waltham,
Massachusetts 02451
|
By: /s/ Peter M. Wilver | |
|
Peter
M. Wilver
|
|
Senior
Vice President, Chief Financial Officer
and
|
|
Member
of the Pension Committee
|
Page(s)
|
||
Report
of Independent Registered Public Accounting Firm
|
1
|
|
Financial
Statements
|
||
Statements of Net Assets
Available for Benefits at December 31, 2008 and 2007
|
2
|
|
Statement of Changes in Net
Assets Available for Benefits for the Year Ended December 31,
2008
|
3
|
|
Notes to Financial
Statements
|
4-9
|
|
Supplemental
Schedule*
|
||
Schedule H, Line 4i – Schedule of
Assets (Held at End of Year)
|
10
|
*
|
Other
supplemental schedules required by Section 2520.103.10 of the Department
of Labor's Rules and Regulations for Reporting and Disclosure
under
the Employee Retirement Income Security Act of 1974 have been omitted
because they are not applicable.
|
(In
thousands)
|
2008
|
2007
|
|||||
Assets
|
|||||||
Investments,
at fair value
|
$ | 15,849 | $ | 24,183 | |||
Receivables
|
|||||||
Participant contributions
|
74 | 91 | |||||
Employer contributions
|
14 | 8 | |||||
88 | 99 | ||||||
Net assets available for benefits at fair value
|
15,937 | 24,282 | |||||
Adjustment from fair value to contract value for collective trust
investments in fully benefit-responsive
investment contracts
|
5 | (10 | ) | ||||
Net assets available for benefits
|
$ | 15,942 | $ | 24,272 |
(In
thousands)
|
2008
|
|||
Additions
|
||||
Investment income (loss)
|
||||
Dividends and interest income
|
$ | 928 | ||
Net depreciation in fair value of investments
|
(8,756 | ) | ||
Total investment loss, net
|
(7,828 | ) | ||
Contributions
|
||||
Employer
|
244 | |||
Participants
|
1,288 | |||
Total contributions
|
1,532 | |||
Total reductions, net
|
(6,296 | ) | ||
Deductions
|
||||
Benefits paid to participants
|
2,034 | |||
Net
decrease in net assets available for benefits
|
(8,330 | ) | ||
Net
Assets Available for Benefits
|
||||
Beginning of year
|
24,272 | |||
End of year
|
$ | 15,942 |
December
31,
|
|||||||
(In
thousands, except shares)
|
2008
|
2007
|
|||||
Mutual
Funds
|
|||||||
T.
Rowe Price Retirement 2020 Fund (1)(2)
|
$ | 3,726 | $ | 5,640 | |||
T.
Rowe Price Retirement 2015 Fund (1)(2)
|
3,025 | 3,874 | |||||
T.
Rowe Price Retirement 2010 Fund (1)(2)
|
2,180 | 3,054 | |||||
T.
Rowe Price Retirement 2025 Fund (1)(2)
|
1,551 | 2,444 | |||||
T.
Rowe Price Retirement 2030 Fund (1)(2)
|
1,233 | 1,663 | |||||
Dodge
& Cox Stock Fund (1)(2)
|
836 | 1,545 | |||||
T.
Rowe Price Retirement 2035 Fund
|
457 | 767 | |||||
Dodge
& Cox International Stock Fund
|
446 | 769 | |||||
Western
Asset Core Plus Bond Fund, Instl.
|
367 | 271 | |||||
T.
Rowe Price Retirement 2040 Fund
|
250 | 469 | |||||
Vanguard
Mid Capitalization Index Fund, Instl.
|
220 | 390 | |||||
T.
Rowe Price Retirement Income Fund
|
216 | 420 | |||||
T.
Rowe Price Retirement 2045 Fund
|
125 | 331 | |||||
T.
Rowe Price Retirement 2005 Fund
|
82 | 84 | |||||
T.
Rowe Price Retirement 2050 Fund
|
5 | 8 |
December
31,
|
|||||||
(In
thousands, except shares)
|
2008
|
2007
|
|||||
Common
Collective Trusts
|
|||||||
T.
Rowe Price Stable Value Fund (2)
|
$ | 541 | $ | 1,640 | |||
T.
Rowe Price Growth Stock Trust
|
198 | 358 | |||||
SSGA
S&P 500 Index Fund
|
182 | 285 | |||||
Jennison
Institutional U.S. Small-Cap Equity Fund
|
182 | 171 | |||||
Common
Stock
|
|||||||
Thermo
Fisher Scientific Inc., 797 shares
|
27 | — | |||||
Total
Investments, at Fair Value
|
$ | 15,849 | $ | 24,183 |
Year
Ended
|
||||
December
31,
|
||||
(In
thousands)
|
2008
|
|||
Mutual
Funds
|
$ | 8,371 | ||
Common
Collective Trusts
|
363 | |||
Common
Stock
|
22 | |||
Net
Decrease in Fair Value
|
$ | 8,756 |
Year
Ended
|
||||
December
31,
|
||||
(In
thousands)
|
2008
|
|||
Mutual
Funds
|
$ | 880 | ||
Common
Collective Trusts
|
48 | |||
Dividends
and Interest Income
|
$ | 928 |
(In
thousands)
|
December
31,
2008
|
Quoted
Prices
in
Active
Markets
(Level
1)
|
Significant
Other
Observable
Inputs
(Level
2)
|
Significant
Unobservable
Inputs
(Level
3)
|
|||||||||
Assets
|
|||||||||||||
Mutual funds
|
$ | 14,719 | $ | 14,719 | $ | — | $ | — | |||||
Common collective trusts
|
1,103 | — | 1,103 | — | |||||||||
Common stock
|
27 | 27 | — | — | |||||||||
Total assets at fair value
|
$ | 15,849 | $ | 14,746 | $ | 1,103 | $ | — |
Identity
of Issue/Borrower,
Lessor or Similar Party
|
Description
of investments including maturity date,
rate of interest, collateral,
par, or maturity value
|
Cost
|
Current
Value
(In
thousands)
|
|||||
Mutual
Funds
|
|
|||||||
T.
Rowe Price
|
T.
Rowe Price Retirement 2020 Fund (1)
|
(2)
|
$ | 3,726 | ||||
T.
Rowe Price
|
T.
Rowe Price Retirement 2015 Fund (1)
|
(2)
|
3,025 | |||||
T.
Rowe Price
|
T.
Rowe Price Retirement 2010 Fund (1)
|
(2)
|
2,180 | |||||
T.
Rowe Price
|
T.
Rowe Price Retirement 2025 Fund (1)
|
(2)
|
1,551 | |||||
T.
Rowe Price
|
T.
Rowe Price Retirement 2030 Fund (1)
|
(2)
|
1,233 | |||||
Dodge
& Cox
|
Dodge
& Cox Stock Fund
|
(2)
|
836 | |||||
T.
Rowe Price
|
T.
Rowe Price Retirement 2035 Fund (1)
|
(2)
|
457 | |||||
Dodge
& Cox
|
Dodge
& Cox International Stock Fund
|
(2)
|
446 | |||||
Western
Asset
|
Western
Asset Core Plus Bond Fund, Instl.
|
(2)
|
367 | |||||
T.
Rowe Price
|
T.
Rowe Price Retirement 2040 Fund (1)
|
(2)
|
250 | |||||
Vanguard
|
Vanguard
Mid Capitalization Index Fund, Instl.
|
(2)
|
220 | |||||
T.
Rowe Price
|
T.
Rowe Price Retirement Income Fund (1)
|
(2)
|
216 | |||||
T.
Rowe Price
|
T.
Rowe Price Retirement 2045 Fund (1)
|
(2)
|
125 | |||||
T.
Rowe Price
|
T.
Rowe Price Retirement 2005 Fund (1)
|
(2)
|
82 | |||||
T.
Rowe Price
|
T.Rowe
Price Retirement 2050 Fund (1)
|
(2)
|
5 | |||||
Total
Mutual Funds
|
14,719 | |||||||
Common
Collective Trusts
|
||||||||
T.
Rowe Price
|
T.
Rowe Price Stable Value Fund (1)
|
(2)
|
546 | |||||
T.
Rowe Price
|
T.
Rowe Price Growth Stock Trust (1)
|
(2)
|
|
198 | ||||
State
Street Global Advisors
|
SSGA
S&P 500 Index Fund
|
(2)
|
182 | |||||
Jennison
|
Jennison
Institutional U.S. Small-Cap Equity Fund
|
(2)
|
182 | |||||
Total
Common Collective Trust Funds
|
1,108 | |||||||
Common
Stock
|
||||||||
Thermo
Fisher Scientific Inc.
|
Common
Stock (1)
|
(2)
|
27 | |||||
Total
Investments
|
$ | 15,854 |